Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS block adjuvants for postoperative analgesia in breast cancer surgery
ACTRN12617000851369Phase 2Withdrawn
- Sponsor
- Amira Soliman
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Ketamine + bupivacaine PECS block, Dexmedetomidine + bupivacaine PECS block and Bupivacaine PECS block (3 arms). Primary endpoints: Total postoperative morphine consumption and Time to first analgesic request. Planned start Jun 2017; status: withdrawn.
02
Drugs
bupivacaineketaminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12617000851369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000851369.